- Home
- FMN vs ECOR Comparison
FMN vs ECOR Comparison
Compare FMN & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMN
- ECOR
- Stock Information
- Founded
- FMN 2002
- ECOR 2005
- Country
- FMN United States
- ECOR United States
- Employees
- FMN N/A
- ECOR N/A
- Industry
- FMN Investment Managers
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FMN Finance
- ECOR Health Care
- Exchange
- FMN Nasdaq
- ECOR Nasdaq
- Market Cap
- FMN 127.6M
- ECOR 110.4M
- IPO Year
- FMN N/A
- ECOR 2018
- Fundamental
- Price
- FMN $11.28
- ECOR $17.67
- Analyst Decision
- FMN
- ECOR Strong Buy
- Analyst Count
- FMN 0
- ECOR 1
- Target Price
- FMN N/A
- ECOR $25.00
- AVG Volume (30 Days)
- FMN 22.8K
- ECOR 104.7K
- Earning Date
- FMN 01-01-0001
- ECOR 03-12-2025
- Dividend Yield
- FMN 3.86%
- ECOR N/A
- EPS Growth
- FMN N/A
- ECOR N/A
- EPS
- FMN N/A
- ECOR N/A
- Revenue
- FMN N/A
- ECOR $23,327,000.00
- Revenue This Year
- FMN N/A
- ECOR $59.81
- Revenue Next Year
- FMN N/A
- ECOR $38.49
- P/E Ratio
- FMN N/A
- ECOR N/A
- Revenue Growth
- FMN N/A
- ECOR 74.10
- 52 Week Low
- FMN $9.09
- ECOR $5.32
- 52 Week High
- FMN $11.31
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- FMN 60.55
- ECOR 55.62
- Support Level
- FMN $11.01
- ECOR $15.83
- Resistance Level
- FMN $11.30
- ECOR $19.43
- Average True Range (ATR)
- FMN 0.09
- ECOR 1.19
- MACD
- FMN 0.02
- ECOR 0.17
- Stochastic Oscillator
- FMN 72.97
- ECOR 58.06
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers.. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.